TXN and plasma cell myeloma: In conclusion, this research confirms that Trx1 inhibition results in ROS-induced apoptosis in MM cells, sensitizes MM cells to the NF-кβ inhibitors, and also induces apoptosis in bortezomib-resistant myeloma cells.